20 Dividend Stocks That Billionaires Are Piling On
Numerous billionaire money managers, including the likes of Warren Buffett and Ken Fisher, absolutely love dividend stocks (check out a list of Ken Fisher's favorite dividend ...
Posts Tagged ‘AbbVie Inc (ABBV)’
Flowhub is Automating Cannabis From Seed to Sale
There is no doubt that the marijuana industry in the US has a lot of growth potential.
15 Best Selling Most Profitable Drugs of All Time
Curious to know which treatments are among the 15 bestselling most profitable drugs of all time? The pharmaceutical industry has been a topic of interest for investors, market...
Top 10 Largest Pharmaceutical Companies By Revenue in 2017
The top 10 largest pharmaceutical companies by revenue in 2017 are leading companies that have a large geographical presence, loyal customer base and technologically advanced ...
15 Biggest Healthcare Companies in USA
If you're seeking to invest in stocks with great long-term potential and are interested in adding some exposure to the healthcare sector, then the 15 biggest healthcare companies...
This Fund’s Picks Gained 200% In A Year And Why No One Knows About It
You probably haven't heard of Alex Denner's Sarissa Capital Management, which is a shame, as the fund is coming off a first-quarter in which its stock picks in companies valued...
10 Most Advanced Technologies In The World Today
Let’s focus on the 10 most advanced technologies in the world today, to highlight the great job done by our scientists and innovators.
12 Health Benefits of Medical Marijuana According To Publicly Traded Weed Companies
Yes, you read the title right there are at least 12 health benefits of medical marijuana according to publicly traded weed companies.
Billionaire Druckenmiller’s Top Dividend Stock Picks
Stanley Druckenmiller was one of the fund managers for the Quantum Fund founded by George Soros.
Billionaire Larry Robbins Knows How To Pick Mega-Cap Stocks
Larry Robbins’ Glenview Capital Management reported an equity portfolio worth over $13.98 billion in its latest 13F filing.
Billionaire Larry Robbins Confidently Piles Into CBS, Anthem, As Merger Battles Continue
Larry Robbins is a billionaire investor and businessman who founded the New York-based hedge fund Glenview Capital in 2000. Mr.
AbbVie Inc (ABBV) Stock: Skyrocketing On IP Chatter | Coherus Biosciences Inc (CHRS) Stock Tanking
AbbVie Inc (NYSE:ABBV) and Coherus Biosciences Inc (NASDAQ:CHRS) were both off to a relatively normal start in the market today.
Trending Stocks: Davita, Nordstrom, AbbVie, and More
Despite the fact that the polls are narrowing and November 8 is just over a week away, the markets are rather calm, as all three indexes are moderately in the green.
VeriFone (PAY), Genesco (GCO): Analysts Slashed Their Price Targets On These 5 Stocks Last Week
Although the fundamental prospects for many companies are strong given the robust U.S.
M&A Smorgasbord for NextEra, Plus Earnings Results from Exxon, AbbVie, 2 Other Companies
The Nasdaq and all other major indexes are in the red this morning despite tech heavyweights Amazon.com, Inc.
Why Are These Stocks in the Red Today?
After opening flat, the three indexes have sold off again.
Why Adamis Pharmaceuticals, Immunomedics and Three Other Stocks Are Deep in Red Today?
Markets are trading higher on Monday, as HSBC Holdings PLC said in a report earlier today that the markets are poised to remain bullish.
Five Dividend Stocks Hedge Funds Love
Oil baron and America's first billionaire John D. Rockefeller once said, 'do you know the only thing that gives me pleasure? It's to see my dividends coming in'.
Billionaire Larry Robbins’ Top Healthcare Picks for Q2
Larry Robbins' Glenview Capital has been underperforming the broader market and the overall hedge fund industry for over a year now.
Stumbling Biotech Stocks Spell Doom for Baker Bros. Advisors
While several hedge funds have suffered enormous losses this year due to their investments in biotech stocks, the performance of the leading biotech-focused hedge fund Baker Bros...
Why These 5 Stocks Are Trending Today
The markets are trading in the red today after investor sentiment was dented following the Labor Department's assertion that the U.S economy inched up by 0.5% in the first quarter...
Tipp Hill Cashes Out of Gold Stocks, Puts It Into Healthcare
Syracuse University graduate Richard L. Haydon named his fund after the Tipperary Hill area, his childhood neighborhood.
Why Are Investors Excited About These 5 Stocks Today?
The markets are going nowhere today, after the IMF cut its global growth forecast for the fourth time over the past twelve months, due to China's slowdown.
Stocks Financial Advisors Are Interested In: Costco, Facebook & More
Last week was marked by the S&P 500 entering into its eighth year of bull run amid an increase in oil prices and hopes of more stimulus from central banks.
Do Hedge Funds Love AbbVie Inc (ABBV)?
After years of low interest rates, retail investors continue to starve for income while awaiting higher yields.
Five Dividend Aristocrats Hedge Funds Are Bullish On
Amid the latest market volatility, dividend investing is one of the safest bets on the equity markets.
The Stock Picks of This Obscure Hedge Fund Returned 70.5% In 2015; See What It’s Betting On in 2016
Although Los Angeles-based, biotech-focused hedge fund DAFNA Capital Management has been in operation for the past 17 years, chances are that very few people have heard its name...
Healthcare-focused Baker Bros. Advisors’ Top Picks: Incyte, Alexion, ACADIA & More
Baker Bros. Advisors is a New York City-based fund launched in 2000 by Julian and Felix Baker.
Billionaire Larry Robbins’ Big Q4 Moves in Humana Inc. (HUM), CIGNA Corporation (CI) and Others
Billionaire Larry Robbins, the founder of Glenview Capital Management, has been among the most scrutinized and closely-watched hedge fund managers in recent years due to his bullish...
Top 5 Healthcare Bets of World-Class Baker Bros. Advisors
Baker Bros. Advisors is one of the most famous healthcare-focused equity hedge funds in the world today.
Billionaire Glenn Russell Dubin’s 5 Best Stock Ideas for Q4
Highbridge Capital Management, led by Glenn Russell Dubin, recently filed its latest 13F with the U.S.
Billionaire Larry Robbins Has Mixed Sentiment On His Top Picks For Q4
Glenview Capital, led by Larry Robbins, recently submitted its 13F with the Securities and Exchange Commission, disclosing the long positions held in its portfolio at the end ...
Billionaire Jim Simons’ Top High-Dividend Stock Picks
Most individual investors invest in dividend-paying stocks to benefit from the steady streams of dividend checks, but can also take advantage of stock price appreciation as well...
Here Are This Elite Fund’s Top Stock Picks
Christopher C. Grisanti's Grisanti Brown & Partners is a successful hedge fund with a focus on consumer and healthcare stocks. Mr.
Are Beech Hill Advisors’ Top Biotech Stock Picks Poised For A Big Q4?
Beech Hill Advisors is a New York-based registered investment advisor founded by Paul Cantor and Joseph Weiss in 1987. Mr.
Woodford Investment Management Has A Lot Riding On These 5 Stocks
Woodford Investment Management recently filed its Form 13F with the U.S. Securities and Exchange Commission (SEC) for the reporting period of September 30.
A Look at Larry Robbins’ Take on the Pharma Industry and Four Picks He Is Bullish On
Larry Robbins of Glenview Capital is one of the most widely-watched investors on Wall Street.
Why Are These Four Stocks on the Move on Friday?
With the stock market ending the week on a positive note, boosted by strong earnings reported by tech giants, a number of stocks are trending amid large trading volume on the ...
AbbVie, Biogen, Gilead: Smart Money Got Burned Betting on Biotech in Q3
When it rains, it pours, and for big pharma, it certainly poured in the third quarter.
These Stocks Were Upgraded This Morning And Hedge Funds Couldn’t Agree More
Analysts have been busy over the weekend, as a slew of stocks have received upgrades this morning, including one company which was on the receiving end of not one, but two such...
Here’s What Excited Hedge Funds Have To Say About AbbVie Inc (ABBV)
The $98.24 billion biopharmaceutical company AbbVie Inc (NYSE:ABBV) has sparked the attention of quite a few hedge funds according to the data we compiled from the last round ...
Billionaire Larry Robbins Has Healthy Stakes In Health Stocks
Glenview Capital, led by Larry Robbins, has recently published its 13F filing with the SEC, disclosing an equity portfolio worth $25.25 billion.
Hedge Funds Are Pouring Money Into These Stocks
With the data from the latest round of 13F filings now gathered and processed, we’ve identified five stocks that received a large influx of cash in the second quarter from the...
Synageva Biopharma Corp (GEVA) Acquisition Helps Baker Bros. Advisors Top All Others In Q2 Returns
With the rapid pace of M&A happening in the biotechnology sector, Julian Baker and Felix Baker's Baker Bros. Advisors is making a habit of hitting home runs in 2015.
Deerfield Management Bets Big On Company It Polished Ahead Of IPO, Nivalis Therapeutics Inc (NVLS)
Following the initial public offering of Nivalis Therapeutics Inc (NASDAQ:NVLS) today, James E.
Insiders and Hedge Funds Were Right About Halozyme Therapeutics, Inc. (HALO); Now They Are Buying More
David Cohen and Harold Levy of Iridian Asset Management have significantly increased their stake in Halozyme Therapeutics, Inc.
AbbVie Inc (ABBV), Verizon Communications Inc. (VZ): Grisanti Brown & Partners’ Latest 13F Shows Focus on Consumer & Healthcare Stocks
Grisanti Brown & Partners is a multi-billion hedge fund, which focuses on Consumer and Healthcare stocks, managed by Christopher C. Grisanti.
Kris Jenner’s Rock Springs Capital Rides Healthcare Stocks to Big Q1 Gains
Rock Springs Capital Management, managed by Kris Jenner, Gordon Bussard, and Graham McPhail, a healthcare-focused fund based in Baltimore, Maryland rode its top biotech picks ...
Baker Bros. Advisors Hits the Jackpot with Pharmacyclics Inc (PCYC) Sale; Incyte Corporation (INCY) Among Fund’s Other Top Picks
Julian Baker and Felix Baker's Baker Bros. Advisors’ top pick from the end of 2014 has paid off for the fund in a big way in 2015.
Shire PLC (ADR), Allergan, Inc., Time Warner Cable Inc: John Paulson’s Top Merger Picks
John Paulson's Paulson & Co has been having it rough for the past two years, as far as stock picking goes.
Hedge Fund Resource Center
